AKT1 and cancer: The mechanism by which iridoid glycosides inhibit cancer cell proliferation also involves downregulation of the PI3K/Akt pathway and the ERK1/2-cyclin D1 pathway, and the upregulation of Bax and cytochrome c by iridoid glycosides indicates the possibility of programmed cell death due to apoptosis.